212 related articles for article (PubMed ID: 31300732)
1. Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages.
Dharra R; Radhakrishnan VS; Prasad T; Thakur Z; Cirillo JD; Sheoran A; Pandey AK; Kulharia M; Mehta PK
Sci Rep; 2019 Jul; 9(1):10084. PubMed ID: 31300732
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
3. Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein.
Dharra R; Talwar S; Singh Y; Gupta R; Cirillo JD; Pandey AK; Kulharia M; Mehta PK
PLoS One; 2017; 12(9):e0183060. PubMed ID: 28873466
[TBL] [Abstract][Full Text] [Related]
4. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
Front Immunol; 2020; 11():36. PubMed ID: 32117228
[TBL] [Abstract][Full Text] [Related]
5. Could mycobacterial MelF protein (Rv1936) be used as a potential drug target?
Mehta PK; Dharra R; Kulharia M
Future Microbiol; 2018 Sep; 13():1211-1214. PubMed ID: 30238773
[No Abstract] [Full Text] [Related]
6. A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen species.
Subbian S; Mehta PK; Cirillo SL; Bermudez LE; Cirillo JD
Infect Immun; 2007 Jan; 75(1):127-34. PubMed ID: 17030568
[TBL] [Abstract][Full Text] [Related]
7. The ESX-1 Virulence Factors Downregulate miR-147-3p in Mycobacterium marinum-Infected Macrophages.
Zuo X; Wang L; Bao Y; Sun J
Infect Immun; 2020 May; 88(6):. PubMed ID: 32253249
[TBL] [Abstract][Full Text] [Related]
8. Temporal modulation of host aerobic glycolysis determines the outcome of Mycobacterium marinum infection.
Kan Y; Meng L; Xie L; Liu L; Dong W; Feng J; Yan Y; Zhao C; Peng G; Wang D; Lu M; Yang C; Niu C
Fish Shellfish Immunol; 2020 Jan; 96():78-85. PubMed ID: 31775059
[TBL] [Abstract][Full Text] [Related]
9. Murine Mycobacterium marinum Infection as a Model for Tuberculosis.
Lienard J; Carlsson F
Methods Mol Biol; 2017; 1535():301-315. PubMed ID: 27914088
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
[TBL] [Abstract][Full Text] [Related]
11. Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action.
Kim JJ; Lee HM; Shin DM; Kim W; Yuk JM; Jin HS; Lee SH; Cha GH; Kim JM; Lee ZW; Shin SJ; Yoo H; Park YK; Park JB; Chung J; Yoshimori T; Jo EK
Cell Host Microbe; 2012 May; 11(5):457-68. PubMed ID: 22607799
[TBL] [Abstract][Full Text] [Related]
12. A mycobacterial phosphoribosyltransferase promotes bacillary survival by inhibiting oxidative stress and autophagy pathways in macrophages and zebrafish.
Mohanty S; Jagannathan L; Ganguli G; Padhi A; Roy D; Alaridah N; Saha P; Nongthomba U; Godaly G; Gopal RK; Banerjee S; Sonawane A
J Biol Chem; 2015 May; 290(21):13321-43. PubMed ID: 25825498
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D-dependent cathelicidin inhibits Mycobacterium marinum infection in human monocytic cells.
Sato E; Imafuku S; Ishii K; Itoh R; Chou B; Soejima T; Nakayama J; Hiromatsu K
J Dermatol Sci; 2013 Jun; 70(3):166-72. PubMed ID: 23452544
[TBL] [Abstract][Full Text] [Related]
14. Ursolic Acid Activates Intracellular Killing Effect of Macrophages During Mycobacterium tuberculosis Infection.
Podder B; Jang WS; Nam KW; Lee BE; Song HY
J Microbiol Biotechnol; 2015 May; 25(5):738-44. PubMed ID: 25406534
[TBL] [Abstract][Full Text] [Related]
15. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF
Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis.
Rao M; Valentini D; Zumla A; Maeurer M
Int J Infect Dis; 2018 Apr; 69():78-84. PubMed ID: 29501835
[TBL] [Abstract][Full Text] [Related]
17. Severe inhibition of lipooligosaccharide synthesis induces TLR2-dependent elimination of Mycobacterium marinum from THP1-derived macrophages.
Szulc-Kielbik I; Pawelczyk J; Kielbik M; Kremer L; Dziadek J; Klink M
Microb Cell Fact; 2017 Nov; 16(1):217. PubMed ID: 29183333
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Natural Growth of Two Strains of Mycobacterium Marinum for Translational Antituberculosis Drug Development.
Van Wijk RC; van der Sar AM; Krekels EHJ; Verboom T; Spaink HP; Simonsson USH; van der Graaf PH
Clin Transl Sci; 2020 Nov; 13(6):1060-1064. PubMed ID: 32267997
[TBL] [Abstract][Full Text] [Related]
19. A high content microscopy assay to determine drug activity against intracellular Mycobacterium tuberculosis.
Manning AJ; Ovechkina Y; McGillivray A; Flint L; Roberts DM; Parish T
Methods; 2017 Aug; 127():3-11. PubMed ID: 28366666
[TBL] [Abstract][Full Text] [Related]
20. A New ESX-1 Substrate in Mycobacterium marinum That Is Required for Hemolysis but Not Host Cell Lysis.
Bosserman RE; Nicholson KR; Champion MM; Champion PA
J Bacteriol; 2019 Jul; 201(14):. PubMed ID: 30833360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
